2020
DOI: 10.26452/ijrps.v11i1.1946
|View full text |Cite
|
Sign up to set email alerts
|

A review of the preparation, characterization and application of nanostructured lipid carriers

Abstract: Lipid Nanoparticles have gained increased attention during the last few decades. These carrier systems offer many advantages over conventional drug delivery system, including protection of the entrapped active ingredient from environmental (pH) or physiological (immune system, enzymes) degradations, improved bioavailability, prolonged circulation time, sustained release of drug and site specific drug delivery, reduced dose and side effects.  Solid Lipid Nanoparticles (SLN), has been reported as an alternative … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…These lipid nanocarriers in which crystallized lipid particles (with average mean diameters ≤ 500 nm) are dispersed in an aqueous phase containing emulsifier(s), are efficient delivery systems for improving oral bioavailability of lipophilic drugs (the main applications), but in the last years their appropriate use for delivering of hydrophilic drugs has been also investigated [17,18]. NLCs are composed by a lipid matrix containing a blend of solid and liquid lipids (responsible for a lower crystallinity and higher incidence of defects inside the lipid core), surrounded by a surfactant mixture shell [19,20]. Owing to the many imperfections of lipid core, NLCs manifest multiple advantages, the most significant being the improved drug loading capacity (LC%) and release properties along with stable drug incorporation during storage [21,22].…”
Section: Introductionmentioning
confidence: 99%
“…These lipid nanocarriers in which crystallized lipid particles (with average mean diameters ≤ 500 nm) are dispersed in an aqueous phase containing emulsifier(s), are efficient delivery systems for improving oral bioavailability of lipophilic drugs (the main applications), but in the last years their appropriate use for delivering of hydrophilic drugs has been also investigated [17,18]. NLCs are composed by a lipid matrix containing a blend of solid and liquid lipids (responsible for a lower crystallinity and higher incidence of defects inside the lipid core), surrounded by a surfactant mixture shell [19,20]. Owing to the many imperfections of lipid core, NLCs manifest multiple advantages, the most significant being the improved drug loading capacity (LC%) and release properties along with stable drug incorporation during storage [21,22].…”
Section: Introductionmentioning
confidence: 99%